Surgery Websites
LiverSource »  Faculty »  Hepatology »  Francis Y.K. Yao, M.D.
Francis Y.K. Yao, M.D.

Francis Y.K. Yao, M.D.

  • Professor of Clinical Medicine and Surgery,
  • Departments of Medicine and Surgery
  • Medical Director, Liver Transplant Service
  • Director for Community Liaison, Liver Transplant Service

Contact Information

Academic Office
Division of Gastroenterology
513 Parnassus Avenue, Room S-357
San Francisco, CA 94143-0358
Phone: (415) 514-0332
Fax: 415-476-0659
[email protected]
Open Popup

1979-1980 University of San Francisco, Chemistry Major

1980-1983 University of California, Berkeley B.S. Chemistry with High Honors

1983-1987 Albert Einstein College of Medicine. M.D. Medicine

  • 1987-1988 Stanford University Hospital, Intern, Internal Medicine
  • 1988-1990 Stanford University Hospital, Resident, Internal Medicine
  • 1990-1993 Stanford University Hospital, Fellow, Gastroenterology
  • 1995 American Board of Internal Medicine - ABIM 147033 (Re-certification 2008)
  • 1997 American Board of Gastroenterology - ABIM 147033
  • UCSF Helen Diller Family Comprehensive Cancer Center
  • UCSF Liver Transplant Program
  • UCSF Liver Center
  • Hepatitis in Asians
  • Liver Injury and Repair
  • Liver transplantation outcomes including expanded criteria liver transplants
  • Loco-regional therapy for hepatocellular carcinoma

Dr. Francis Yao is a gastroenterologist and medical director of the Liver Transplant Program at UCSF Medical Center. Dr. Yao is a professor of medicine in the UCSF School of Medicine. He also is director of UCSF's Liver Transplant Outreach and Community Liaison Program. In his research, he is interested in liver cancer treatment, particularly related to liver transplants, and has contributed to important publications in this area. His other research interests include hepatitis B infection and outcomes for liver transplantation.

Data provided by UCSF Profiles, powered by CTSI
  1. Mehta N, Kelley RK, Yao FY. Refining the approach to down-staging for hepatocellular carcinoma prior to liver transplantation: Patient selection, local-regional treatments, and systemic therapies. Hepatology. 2023 May 16. View in PubMed
  2. Mehta N, Kotwani P, Norman J, Shui A, Li PY, Saxena V, Chan W, Yao FY. AFP-L3 and DCP are superior to AFP in predicting waitlist dropout in HCC patients: Results of a prospective study. Liver Transpl. 2023 Apr 27. View in PubMed
  3. Huang AC, Dodge JL, Yao FY, Mehta N. National Experience on Waitlist Outcomes for Down-Staging of Hepatocellular Carcinoma: High Dropout Rate in All-Comers. Clin Gastroenterol Hepatol. 2023 06; 21(6):1581-1589. View in PubMed
  4. Giard JM, Dodge JL, Yao FY, Mehta N. Liver Transpl. 2022 Jul 21; 233-235. View in PubMed
  5. Giard JM, Dodge JL, Yao FY, Mehta N. Alpha-fetoprotein slope over 7.5 ng/ml over 3 months before liver transplantation for hepatocellular carcinoma predicts recurrence even after controlling for alpha-fetoprotein at liver transplantation. Liver Transpl. 2023 02 01; 29(2):233-235. View in PubMed
  6. View All Publications


Site Directory